http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1565146-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebd99e516d44882646430c12128c0a36 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0548 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0526 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-18 |
| filingDate | 2003-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_817c444ef948e4b1c42594cfd7237ad0 |
| publicationDate | 2005-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1565146-A2 |
| titleOfInvention | Administration of anti-inflammatory drugs into the central nervous system |
| abstract | Apparatus is provided for delivering a Non Steroidal Anti -Inflammatory Drug (NSAID) supplied to a body of a subject for delivery to at least a portion of a central nervous system (CNS) of the subject via a systemic blood circulation of the subject, including a stimulator (4) adapted to stimulate at least one site of the subject, so as to cause an increase in passage of the NSAID from the systemic blood circulation across a blood brain barrier (BBB) of the subject to the portion of the CNS, during at least a portion of the time that the NSAID is present in the blood, the site selected from the list consisting of: a sphenopalatine ganglion (SPG) (6) of the subject, an anterior ethmoidal nerve of the subject, a posterior ethmoidal nerve of the subject, a communicating branch between an anterior ethmoidal nerve and a retro-orbital branch of an SPG (6) of the subject, a communicating branch between a posterior ethmoidal nerve and a retro-orbital branch of an SPG (6) of the subject, a greater palatine nerve of the subject, a lesser palatine nerve of the subject, a sphenopalatine nerve of the subject, a communicating branch between a maxillary nerve and an SPG (6) of the subject, a nasopalatine nerve of the subject, a posterior nasal nerve of the subject, an infraorbital nerve of the subject, an otic ganglion of the subject, an afferent fiber going into the otic ganglion of the subject, an efferent fiber going out of the otic ganglion of the subject, a vidian nerve of the subject, a greater superficial petrosal nerve of the subject, and a lesser deep petrosal nerve of the subject. |
| priorityDate | 2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 294.